397 related articles for article (PubMed ID: 10381768)
1. Characterization of interaction of 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester with Torpedo californica nicotinic acetylcholine receptor and 5-hydroxytryptamine3 receptor.
Sun H; McCardy EA; Machu TK; Blanton MP
J Pharmacol Exp Ther; 1999 Jul; 290(1):129-35. PubMed ID: 10381768
[TBL] [Abstract][Full Text] [Related]
2. The "calcium antagonist" TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester] is a potent, non-competitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypes.
Bencherif M; Eisenhour CM; Prince RJ; Lippiello PM; Lukas RJ
J Pharmacol Exp Ther; 1995 Dec; 275(3):1418-26. PubMed ID: 8531111
[TBL] [Abstract][Full Text] [Related]
3. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
Arias HR
Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
[TBL] [Abstract][Full Text] [Related]
4. Interaction of barbiturate analogs with the Torpedo californica nicotinic acetylcholine receptor ion channel.
Arias HR; McCardy EA; Gallagher MJ; Blanton MP
Mol Pharmacol; 2001 Sep; 60(3):497-506. PubMed ID: 11502880
[TBL] [Abstract][Full Text] [Related]
5. Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.
Arias HR; Trudell JR; Bayer EZ; Hester B; McCardy EA; Blanton MP
Biochemistry; 2003 Jun; 42(24):7358-70. PubMed ID: 12809491
[TBL] [Abstract][Full Text] [Related]
6. The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface.
Blanton MP; Xie Y; Dangott LJ; Cohen JB
Mol Pharmacol; 1999 Feb; 55(2):269-78. PubMed ID: 9927618
[TBL] [Abstract][Full Text] [Related]
7. Blockage of mouse muscle nicotinic receptors by serotonergic compounds.
García-Colunga J; Miledi R
Exp Physiol; 1999 Sep; 84(5):847-64. PubMed ID: 10502654
[TBL] [Abstract][Full Text] [Related]
8. The muscarinic antagonists aprophen and benactyzine are noncompetitive inhibitors of the nicotinic acetylcholine receptor.
Amitai G; Herz JM; Bruckstein R; Luz-Chapman S
Mol Pharmacol; 1987 Nov; 32(5):678-85. PubMed ID: 3683366
[TBL] [Abstract][Full Text] [Related]
9. Quinacrine and ethidium bromide bind the same locus on the nicotinic acetylcholine receptor from Torpedo californica.
Lurtz MM; Hareland ML; Pedersen SE
Biochemistry; 1997 Feb; 36(8):2068-75. PubMed ID: 9047305
[TBL] [Abstract][Full Text] [Related]
10. Allosterically linked noncompetitive antagonist binding sites in the resting nicotinic acetylcholine receptor ion channel.
Arias HR; McCardy EA; Bayer EZ; Gallagher MJ; Blanton MP
Arch Biochem Biophys; 2002 Jul; 403(1):121-31. PubMed ID: 12061809
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C
Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790
[TBL] [Abstract][Full Text] [Related]
12. The hydrophobic photoreagent 3-(trifluoromethyl)-3-m-([125I] iodophenyl) diazirine is a novel noncompetitive antagonist of the nicotinic acetylcholine receptor.
White BH; Howard S; Cohen SG; Cohen JB
J Biol Chem; 1991 Nov; 266(32):21595-607. PubMed ID: 1939189
[TBL] [Abstract][Full Text] [Related]
13. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cembranoid interaction with the nicotinic acetylcholine receptor.
Hann RM; Pagán OR; Gregory L; Jácome T; Rodríguez AD; Ferchmin PA; Lu R; Eterović VA
J Pharmacol Exp Ther; 1998 Oct; 287(1):253-60. PubMed ID: 9765345
[TBL] [Abstract][Full Text] [Related]
15. Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors.
Arias HR; Feuerbach D; Targowska-Duda KM; Jozwiak K
Neurochem Int; 2010 Sep; 57(2):153-61. PubMed ID: 20493225
[TBL] [Abstract][Full Text] [Related]
16. Identification of amino acids in the nicotinic acetylcholine receptor agonist binding site and ion channel photolabeled by 4-[(3-trifluoromethyl)-3H-diazirin-3-yl]benzoylcholine, a novel photoaffinity antagonist.
Chiara DC; Trinidad JC; Wang D; Ziebell MR; Sullivan D; Cohen JB
Biochemistry; 2003 Jan; 42(2):271-83. PubMed ID: 12525154
[TBL] [Abstract][Full Text] [Related]
17. Agonist-induced photoincorporation of a p-benzoylphenylalanine derivative of substance P into membrane-spanning region 2 of the Torpedo nicotinic acetylcholine receptor delta subunit.
Blanton MP; Li YM; Stimson ER; Maggio JE; Cohen JB
Mol Pharmacol; 1994 Dec; 46(6):1048-55. PubMed ID: 7528876
[TBL] [Abstract][Full Text] [Related]
18. Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors.
Weiland GA; Durkin JA; Henley JM; Simasko SM
Mol Pharmacol; 1987 Nov; 32(5):625-32. PubMed ID: 2446113
[TBL] [Abstract][Full Text] [Related]
19. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: affinity-labeling and mutational analyses identify gamma Tyr-111/delta Arg-113 as antagonist affinity determinants.
Chiara DC; Xie Y; Cohen JB
Biochemistry; 1999 May; 38(20):6689-98. PubMed ID: 10350488
[TBL] [Abstract][Full Text] [Related]
20. Site specificity of agonist-induced opening and desensitization of the Torpedo californica nicotinic acetylcholine receptor.
Andreeva IE; Nirthanan S; Cohen JB; Pedersen SE
Biochemistry; 2006 Jan; 45(1):195-204. PubMed ID: 16388595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
